Zalicus Acquires EPIRUS Biopharmaceuticals for Undisclosed Sum

  • Feed Type
  • Date
  • Company Name
    EPIRUS Biopharmaceuticals
  • Mailing Address
    699 Boylston Street 11th Floor Boston, MA 02199 USA
  • Company Description
    The biopharmacuticals industry is approaching an unprecedented biologics patent cliff, with emerging markets forging their own regulatory landscapes. EPIRUS is seizing the opportunity with a new business model that adapts to the changing dynamics and regulations of today’s market conditions.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the deal were not disclosed.

Trending on Xconomy